Identifying Potential Drug Targets for Treating ADHD From a Genetic Perspective: A Mendelian Randomization Study.
Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder. Current pharmacological treatments have limitations, highlighting the need for new therapeutic targets. Using two-sample Mendelian randomization with cis-expression quantitative trait loci from the eQTLGen Consortium (31,684 indiv...